The novel therapy of this peptide represents a major development in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects dual pathways – the GLP-1 hormone and GIP – leading to https://tirzepatidepeptide625643.newbigblog.com/48994209/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment